Regorafenib shown to augment antitumor effect of anti-PD-1 immunotherapy in advanced gastric cancers

byKumamoto UniversityCredit:Cancer Research(2022). DOI: 10.1158/0008-5472.CAN-22-1890Fibrotic cancers such as gastric cancers are highly resistant to conventional therapies like immu

Updated on: January 03,2024 8

Regorafenib shown to augment antitumor effect of anti-PD-1 immunotherapy in advanced gastric cancers

byKumamoto UniversityCredit:Cancer Research(2022). DOI: 10.1158/0008-5472.CAN-22-1890Fibrotic cancers such as gastric cancers are highly resistant to conventional therapies like immu

Updated on:January 03,2024 8

New AI-based biomarker can help predict immunotherapy response for patients with lung cancer

byEmory UniversityResponder tumor to ICI has less tortuous vessel branches compared to nonresponder. (A and B) CT scans of a responder and nonresponder to IO with corresponding 3D rendering of t

Updated on: January 12,2024 9

New AI-based biomarker can help predict immunotherapy response for patients with lung cancer

byEmory UniversityResponder tumor to ICI has less tortuous vessel branches compared to nonresponder. (A and B) CT scans of a responder and nonresponder to IO with corresponding 3D rendering of t

Updated on:January 12,2024 9

Glioma subtypes determine how the dangerous tumors spread, evade anti-angiogenic treatment

by Massachusetts General HospitalTumorous glial cells, labeled in green, have overtaken most of an adult fly brain. Glial cell nuclei are shown in red. Credit: Courtesy of Dr. Renee Read, Salk In

Updated on: March 01,2024 16

Glioma subtypes determine how the dangerous tumors spread, evade anti-angiogenic treatment

by Massachusetts General HospitalTumorous glial cells, labeled in green, have overtaken most of an adult fly brain. Glial cell nuclei are shown in red. Credit: Courtesy of Dr. Renee Read, Salk In

Updated on:March 01,2024 16

Study sends strong signal not to sequence immune checkpoint inhibitors in advanced kidney cancer

byDana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainPatients with advanced kidney cancer are routinely given immune checkpoint inhibitors (ICIs) as first-line treatment. The CONTACT-0

Updated on: January 22,2024 17

Study sends strong signal not to sequence immune checkpoint inhibitors in advanced kidney cancer

byDana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainPatients with advanced kidney cancer are routinely given immune checkpoint inhibitors (ICIs) as first-line treatment. The CONTACT-0

Updated on:January 22,2024 17

Researchers claim vitamin supplements and new technology can help prevent secondary stroke

by Marcus Wolf,University of MaineCredit:Pharmacogenomics and Personalized Medicine(2023). DOI: 10.2147/PGPM.S426421A team of researchers, including one from the University of Maine,

Updated on: June 06,2024 7

Researchers claim vitamin supplements and new technology can help prevent secondary stroke

by Marcus Wolf,University of MaineCredit:Pharmacogenomics and Personalized Medicine(2023). DOI: 10.2147/PGPM.S426421A team of researchers, including one from the University of Maine,

Updated on:June 06,2024 7

Study: 'GPS' seed devices effective in localizing breast tumors

by Tim Tedeschi,University of CincinnatiCredit: Pixabay/CC0 Public DomainUniversity of Cincinnati Cancer Center researchers found a seed device that acts as a GPS for surgeons to locate and remo

Updated on: March 06,2024 17

Study: 'GPS' seed devices effective in localizing breast tumors

by Tim Tedeschi,University of CincinnatiCredit: Pixabay/CC0 Public DomainUniversity of Cincinnati Cancer Center researchers found a seed device that acts as a GPS for surgeons to locate and remo

Updated on:March 06,2024 17

Researchers create machine learning model to calculate chemotherapy success in patients with osteosarcoma

by Johns Hopkins University School of MedicineA microscopic image of intramedullary osteosarcoma. Johns Hopkins researchers have trained a machine learning model use such images to calculate perc

Updated on: June 24,2024 6

Researchers create machine learning model to calculate chemotherapy success in patients with osteosarcoma

by Johns Hopkins University School of MedicineA microscopic image of intramedullary osteosarcoma. Johns Hopkins researchers have trained a machine learning model use such images to calculate perc

Updated on:June 24,2024 6

Researchers identify a potential new target for head and neck cancer immunotherapy

by University of California - San DiegoCorrelation between TERT and T/B cell infiltrate varies across solid cancers and predicts survival. (A) Spearman correlation between TERT mRNA expression an

Updated on: February 01,2024 15

Researchers identify a potential new target for head and neck cancer immunotherapy

by University of California - San DiegoCorrelation between TERT and T/B cell infiltrate varies across solid cancers and predicts survival. (A) Spearman correlation between TERT mRNA expression an

Updated on:February 01,2024 15

Researchers discover cell 'crosstalk' that triggers cancer cachexia

byUniversity of OklahomaGraphical abstract. Credit:Cancer Cell(2024). DOI: 10.1016/j.ccell.2024.03.009New research from the University of Oklahoma reveals a previously unknown chain

Updated on: April 30,2024 0

Researchers discover cell 'crosstalk' that triggers cancer cachexia

byUniversity of OklahomaGraphical abstract. Credit:Cancer Cell(2024). DOI: 10.1016/j.ccell.2024.03.009New research from the University of Oklahoma reveals a previously unknown chain

Updated on:April 30,2024 0

Aumolertinib shows improved progression-free survival in stage III non-small cell lung cancer

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe epidermal growth factor receptor tyrosine kinase inhibitor aumolertinib demonstrated improved progression-

Updated on: September 27,2024 0

Aumolertinib shows improved progression-free survival in stage III non-small cell lung cancer

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe epidermal growth factor receptor tyrosine kinase inhibitor aumolertinib demonstrated improved progression-

Updated on:September 27,2024 0

Updated policy regarding electronic nicotine delivery systems

by Yale Cancer CenterPercentage of various school age groups who vaped in the past 30 days. Blue lines indicate data from the NYTS (51, 52, 54–60), and red lines indicate data from the MTF survey (53)

Updated on: January 30,2024 19

Updated policy regarding electronic nicotine delivery systems

by Yale Cancer CenterPercentage of various school age groups who vaped in the past 30 days. Blue lines indicate data from the NYTS (51, 52, 54–60), and red lines indicate data from the MTF survey (53)

Updated on:January 30,2024 19

Inhibitor shows lasting structural integrity and long terminal half-life in tumor tissue

by Vall d'Hebron Institute of OncologyLaura Soucek, co-Director of Preclinical and Translational Research at VHIO, Chief Executive Officer of Peptomyc, and an ICREA Research Professor. Credit: VHI

Updated on: February 18,2024 18

Inhibitor shows lasting structural integrity and long terminal half-life in tumor tissue

by Vall d'Hebron Institute of OncologyLaura Soucek, co-Director of Preclinical and Translational Research at VHIO, Chief Executive Officer of Peptomyc, and an ICREA Research Professor. Credit: VHI

Updated on:February 18,2024 18